- Home
- / Hemagen
Hemagen
Stock Price
$0
2024-10-29
Market Capitalization
$387.5 K
2024-10-29
Revenue
$4 M
FY, 2012
Hemagen Summary
Company Summary
- Overview
- Hemagen Diagnostics is a company offering diagnostic test kits. It is focused on veterinary clinical diagnostics and a human clinical diagnostic line of autoimmune and infectious disease products.
- Type
- Public
- Status
- Active
- Founded
- 1985
- HQ
- Columbia, MD, US | view all locations
- Website
- https://www.hemagen.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Columbia, MD HQ
United States
9033 Red Branch Rd
Hemagen Financials
Summary Financials
- Revenue (FY, 2012)
- $4.0M
- Gross profit (FY, 2012)
- $1.6M
- Net income (FY, 2012)
- ($907.3K)
- Cash (FY, 2012)
- $66.3K
- EBIT (FY, 2012)
- ($437.9K)
- Enterprise value
- $1.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026